Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05637671
What this trial is testing

Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms

Who this might be right for
Vasomotor Symptoms
Cairo University 146
Testing effectiveness (Phase 2)Ended earlyNCT00880009
What this trial is testing

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT02339532
What this trial is testing

Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status

Who this might be right for
Breast Cancer
UNICANCER 86
Not applicableLooking for participantsNCT05057598
What this trial is testing

DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 50,000
Testing effectiveness (Phase 2)Ended earlyNCT00903006
What this trial is testing

Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 11
Not applicableUnknownNCT03333226
What this trial is testing

Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial)

Who this might be right for
Breast Cancer Lymphedema
University Hospital of Ferrara 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04920708
What this trial is testing

Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

Who this might be right for
Metastatic Breast CancerER+ Breast CancerAdvanced Breast Cancer
Royal Marsden NHS Foundation Trust 57
Not applicableLooking for participantsNCT07617025
What this trial is testing

Prognostic and Predictive Role of Intrinsic Molecular Subtypes in BRCA-associated Breast Cancer

Who this might be right for
Breast Cancer
Angela Toss 100
Testing effectiveness (Phase 2)Ended earlyNCT04489940
What this trial is testing

Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
EMD Serono Research & Development Institute, Inc. 11
Not applicableStudy completedNCT01641068
What this trial is testing

Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms

Who this might be right for
Breast CarcinomaCancer SurvivorCognitive Side Effects of Cancer Therapy+1 more
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT02525718
What this trial is testing

Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction

Who this might be right for
Breast Cancer
Northwestern University 47
Not applicableLooking for participantsNCT05502224
What this trial is testing

Multidisciplinary Approach to Fatigue

Who this might be right for
Breast CancerGerm Cell Tumor
Jules Bordet Institute 50
Not applicableStudy completedNCT05260723
What this trial is testing

RISE - Reduce Sitting Time Among Breast Cancer Survivors

Who this might be right for
Sedentary BehaviorSedentary TimeBreast Cancer
University of California, San Diego 21
Not applicableUnknownNCT00912080
What this trial is testing

Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Institut Paoli-Calmettes 375
Testing effectiveness (Phase 2)Study completedNCT04758780
What this trial is testing

Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Institut Cancerologie de l'Ouest 12
Testing effectiveness (Phase 2)Looking for participantsNCT06125080
What this trial is testing

The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Huihua Xiong 78
Not applicableLooking for participantsNCT06833255
What this trial is testing

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Who this might be right for
Breast Carcinoma
Roswell Park Cancer Institute 125
Not applicableStudy completedNCT04979715
What this trial is testing

The Effect of Early Rehabilitation After Breast Cancer Surgery on Physical and Psychosocial Functions

Who this might be right for
Breast Cancer Surgery
Pamukkale University 63
Testing effectiveness (Phase 2)Study completedNCT01380808
What this trial is testing

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Fudan University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04975308
What this trial is testing

Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 874
Next Page